Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion

Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients

DURHAM, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the opening of its expanded non-commercial specialty pharmacy, FortreaRx™, located in Lake Mary, Florida, which offers advanced patient access solutions across the United States, including ambient and cold-chain distribution capabilities and expertise.

Licensed in all 50 states and U.S. territories, FortreaRx delivers flexible, scalable solutions that meet the specific needs of its customers while providing medications to patients who may otherwise not have access to them. Non-commercial specialty pharmacies, like FortreaRx, provide these solutions on behalf of their pharmaceutical manufacturer customers and are uniquely positioned to serve as a bridge between pharmaceutical manufacturers and patients who meet the manufacturer requirements for prescription assistance.

Since FortreaRx’s inception in late 2008, Fortrea has pioneered non-commercial specialty pharmacy services, focusing exclusively on the distribution of free-goods products as an integrated component of pharmaceutical manufacturer-sponsored patient assistance programs (PAP) designed to expand access to therapy for qualified patients with no health insurance or those who are underinsured. The FortreaRx 40,000-square-foot facility doubles its operational space and bolsters its capabilities, delivering:

  • 1,800 square feet of ambient storage
  • 6,000+ square feet of cold chain storage with more than 85 percent of prescriptions filled by FortreaRx requiring this unique handling
  • Greater processing and fulfillment space for up to 18,000 prescriptions daily
  • Enhanced shipping solutions with options for overnight, expedited and 2-day deliveries

“Fortrea’s well-established patient services offerings, combined with the expanded capabilities of FortreaRx, deliver an end-to-end approach, from early clinical stages to post-market delivery, ensuring a comprehensive and personalized experience for patients,” said Bill Nolan, vice president and global head of Patient Access at Fortrea. “From our expertise in broad-range disease states to our unwavering commitment to patient assistance, Fortrea excels at delivering timely and impactful solutions to our pharmaceutical sponsors that strive to reduce patient and provider challenges by streamlining enrollment processes and by offering full integration with broader patient support initiatives.”

FortreaRx’s call center hub of case managers seamlessly manages patient inquiries, counseling and data verification of prescriptions. Fortrea’s patient access team helps patients and providers understand and navigate the complexities of coverage while removing obstacles to get medication to patients.

FortreaRx delivers efficient, consultative and cost-effective solutions for manufacturer prescription programs typically resulting in significant yearly savings for patients.

For more information about FortreaRx and its services, please visit Fortrea.com.

About Fortrea

Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of about 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter) @Fortrea.

Fortrea Contacts:
Fortrea Media: Galen Wilson – 703-298-0802, [email protected]
Fortrea Media: Kate Dillon – 646-818-9115, [email protected]

GlobeNewswire Distribution ID 9040223

Axi Select hailed as the future of prop trading as multiple demo account firms close doors due to pressures from regulators, brokers, and tech providers

Axi Select

Axi Select hailed as the future of prop trading as multiple demo account firms close doors due to pressures from regulators, brokers, and tech providers

SYDNEY, Australia, Feb. 20, 2024 (GLOBE NEWSWIRE) — Bucking the trend of recent negative developments in the prop firm industry, leading global CFD and FX broker Axi, which launched Axi Select – their unique capital allocation programme for talented traders – has been hailed by many industry experts as the future of the industry.

Recent issues experienced in the prop trading industry have resulted in multiple firms having to pause or close down their service due to pressure from regulators, partner brokers or tech providers.

Axi Select is completely different to the industry, and as a result has legitimised the prop firm model by offering a live trading account programme, with real controls in terms of execution, transparency, and fair market conditions. Since its launch in mid-2023, Axi Select has witnessed an incredible 40% month-on-month increase in the number of active clients on their platforms.

Axi believes their Select programme is revolutionary, sustainable and is the future of the prop firm model. Greg Rubin, Head of Axi Select, stated “In the last week the prop trading industry has been turned on its head completely with multiple firms having to suspend their services due to external pressures.

“We foresaw this, which is why we’ve developed a capital allocation programme which is built on our live trading account model and has been available in over 100 countries for more than 16 years. This has given us the confidence that Axi Select is a long-term solution to the prop trading community, and not subject to the issues now faced by prop firms who offer the demo account registration fee model and are under constant pressure from regulators and their tech partners.”

He continued “We genuinely empathise with the thousands of talented traders who will now be denied access to their allocated funds, and we encourage anyone using the demo trading registration model to question whether their prop firm partner will be able to continue as an ongoing concern given recent events. Unfortunately, this could be the beginning of the end for the demo account prop firm model.”

Axi Select offers a very attractive funding model – $1 million USD top allocation and clients can keep up to 90% of their profits – that’s one of the top allocation offerings worldwide, from an award-winning globally recognised, respected, and trusted broker.

By joining Axi you don’t need to pay a registration fee. Yes, you need to fund your trading account, but that money is yours to withdraw at any time and any profits you make on your funded account, you keep in addition to funds allocated by Axi.

“We believe passionately that Axi Select is the best allocation programme globally” said Rajesh Yohannan, Group CEO of Axi.

“By using a live trading account, with real money and the emotions that accompany this, we believe you are more likely to be profitable longer term and make money from your own live account as well as the funded proportion. Our Axi Select account has all the controls we offer to our live account holders globally. This includes access to our award-winning fast, transparent, and fair-trade execution.”

He added “If you are a talented trader and are looking for a legitimate funding programme which is designed to truly help you succeed and profit from the financial markets, and you want the stability of an account model which has been in market for 16 years, then Axi Select is the place for you to find your Edge.”

About Axi Select*

Axi Select* is a unique capital allocation programme that was specifically designed to help you succeed as a professional trader. Axi Select* offers a generous funding of up to $1 million USD as part of a structured and fair pathway to help you meet your long-term and most ambitious trading aspirations. Solidify your trading skills, knowledge and understanding of the markets and embark on your biggest trading journey ever with Axi through Axi Select.

Why Axi Select*?

  • 100% Free to join – No registration fees
  • Earn 90% of profits on $1,000,000 USD of our funds
  • Unrestrictive trading conditions & a structured pathway that provides a fair & real opportunity for traders to become professional traders
  • Trading score (Edge score) to assess & assist with trading performance
  • Dashboard with analytics, advanced stats, and a leader board
  • Exclusive online trading room with live analysis and learning videos from professional traders. Ability to interact with fellow traders and share analysis/trading ideas.
  • Trustworthy broker with over 35+ industry awards.

Axi

How is Axi Select* different from other programmes?

Programme Axi Select Industry Standard
Registration fee No Yes
Pass Evaluation No Yes
Restrictive Trading Conditions No Varies
Number of Attempts 3 1
Leverage 100:1 Varies, majority less than 100:1
Account Type Real Trading Account Demo
Additional Tools Dashboard/Leaderboard, Edge Score, Trading Room Varies

Learn more & switch to Axi Select: https://www.axi.com/select

* The Axi Select programme is only available to clients of AxiTrader Limited. CFDs carry a high risk of investment loss. In our dealings with you, we will act as a principal counterparty to all of your positions. This content is not available for AU, NZ, EU, and UK residents. For more information, refer to our Terms of Service. Other fees and minimum deposit apply.

About Axi

Axi is a global online FX and CFD trading company, trusted by thousands of ambitious customers in 100+ countries around the world. We help all types of traders, trading businesses, banks and financial organizations find the edge they need to achieve their financial goals through informed transactions made on the world’s financial markets. Axi offers a wide range of assets including CFDs for several asset classes including Forex, Shares, Gold, Silver, Oil, Coffee, Indices, and other commodities.

At Axi, we are proud of our reputation as an honest, fair, and trusted broker. Our many awards and ‘Great’ Trustpilot reviews prove we have earned the confidence of customers who value our outstanding service, fast execution, secure payments, segregated funds, and easy withdrawals.

For further enquiries contact [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4b7f4608-f090-471c-995d-de6c0f23438e

GlobeNewswire Distribution ID 1000914826

K1 Investment Management, LLC (“K1”) Statement regarding Possible Offer for MariaDB plc (“MariaDB”)

POSSIBLE OFFER (RULE 2.4 ANNOUNCEMENT)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT UNDER RULE 2.4 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 (THE “TAKEOVER RULES”) AND IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE TAKEOVER RULES. THERE CAN BE NO CERTAINTY THAT ANY OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY SUCH OFFER WILL BE MADE.

LOS ANGELES, Feb. 16, 2024 (GLOBE NEWSWIRE) — K1 confirms that it made, on 15 February 2024, a non-binding proposal to the board of directors of MariaDB (the “Board”) to acquire, together with K1’s investment affiliates, all of the issued, and to be issued, share capital of MariaDB at a value of $0.55 per share (the “Possible Offer”). The terms of the Possible Offer represent:-

  • (i) a 189% premium to MariaDB’s closing share price on February 5, 2024, the last full trading day prior to the announcement by MariaDB of a potential forbearance agreement with RP Ventures LLC and Hale Capital Partners; and
  • (ii) a 114% premium to MariaDB’s average closing share price of the last 30 calendar days.

K1 has a high regard for the MariaDB business and looks forward to engaging with MariaDB in connection with the Possible Offer.

It is intended that the proposed transaction would be effected by way of an Irish law scheme of arrangement whereby K1, or its affiliates, would acquire 100% of the issued shares of the Company. However, K1 reserves the right to implement the proposal, instead, by way of contractual offer. The form and/or mix of the offer consideration has not yet been determined.

There can be no certainty that any offer will be made, nor as to the terms on which any such offer might be made.

In accordance with Rule 2.6(a) of the Irish Takeover Rules, K1 must, by no later than 5.00 p.m. on 29 March 2024 either announce a firm intention to make an offer for MariaDB in accordance with Rule 2.7 of the Irish Takeover Rules or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Irish Takeover Rules applies. This deadline may be extended with the consent of the Panel in accordance with Rule 2.6(c) of the Irish Takeover Rules.

Pursuant to Rule 2.5 of the Irish Takeover Rules, K1 reserves the right to amend the terms of any offer (including making the offer on less favourable terms or at a lower value than US$0.55 per share):

a) with the recommendation or consent of the Board, or an independent committee of the Board (as appropriate);

b) if any dividend or any other distribution or return of value is paid or becomes payable by MariaDB to MariaDB shareholders after the date of this announcement, in which case K1 will have the right to reduce the offer consideration by the amount of any dividend (or other distribution or return of value) which is paid or becomes payable by Maria DB to MariaDB shareholders;

c) following the announcement by MariaDB of a whitewash transaction pursuant to the Irish Takeover Rules on less favourable terms than those set out in this announcement; or

d) if a third party announces a firm intention to make an offer for MariaDB on less favourable terms than those set out in this announcement or at a lower value than $0.55 per share.

A further announcement will be made as and when appropriate.

Contacts:

Lazard (Financial Advisor to K1)

Adrian Duchini, Keiran Wilson, Charles White   +44 20 7187 2000

About K1

K1 is a global investment firm that builds category-leading enterprise software companies and has over $13 billion of assets under management. K1 partners with strong management teams of high-growth technology businesses to help them achieve successful outcomes. With over 125 professionals, K1 and its operating affiliate, K1 Operations LLC, change industry landscapes with operationally focused growth strategies designed to rapidly scale portfolio companies. Since the inception of the firm, K1 has partnered with over 200 enterprise software companies including industry leaders such as Axcient, Checkmarx, Emburse, Elmo, Granicus, Litera Microsystems, Onit, Reveal-Brainspace, simPRO, Smarsh, and XTM International.

Responsibility statement

The K1 Responsible Persons (being the investment committee of K1) accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the K1 Responsible Persons (who have taken all reasonable care to ensure that such is the case) the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

Important notice relating to financial adviser

Lazard Frères & Co. LLC, together with its affiliate Lazard & Co., Limited (which is authorised and regulated in the United Kingdom by the Financial Conduct Authority) (“Lazard”), is acting exclusively as financial adviser to K1 and no one else in connection with the Possible Offer and will not be responsible to anyone other than K1 for providing the protections afforded to clients of Lazard nor for providing advice in relation to the Possible Offer or any other matters referred to in this announcement. Neither Lazard nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard in connection with this announcement, any statement contained herein or otherwise.

Further Information; No Offer or Solicitation

This announcement does not constitute an offer to sell or invitation to purchase any securities, or the solicitation of any vote or approval in any jurisdiction pursuant to the Possible Offer or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. In particular, this announcement is not an offer of securities for sale into the United States. No offer of securities shall be made in the United States absent registration under the Securities Act of 1933, as amended, or pursuant to an exemption from, or in a transaction not subject to, such registration requirements. The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

Disclosure Requirements under the Irish Takeover Rules

Under Rule 8.3(a) of the Irish Takeover Rules, any person who is ‘interested’ in 1% or more of any class of ‘relevant securities’ of MariaDB or a securities exchange offeror (being any offeror other than an offeror which has announced that its offer is, or is likely to be, solely in cash) must make an ‘opening position disclosure’ following the commencement of the ‘offer period’ and, if later, following the announcement in which any securities exchange offeror is first identified. An ‘opening position disclosure’ must contain, among other things, details of the person’s ‘interests’ and ‘short positions’ in any ‘relevant securities’ of each of (i) MariaDB and (ii) any securities exchange offeror(s). An ‘opening position disclosure’ by a person to whom Rule 8.3(a) applies must be made by no later than 3:30 pm (Irish time) on the day that is ten ‘business days’ following the commencement of the ‘offer period’ and, if appropriate, by no later than 3:30 pm (Irish time) on the day that is ten ‘business days’ following the announcement in which any securities exchange offeror is first identified.

Under Rule 8.3(b) of the Irish Takeover Rules, if any person is, or becomes, ‘interested’ (directly or indirectly) in 1% or more of any class of ‘relevant securities’ of MariaDB, all ‘dealings’ in any ‘relevant securities’ of MariaDB or any securities exchange offeror (including by means of an option in respect of, or a derivative referenced to, any such ‘relevant securities’) must be publicly disclosed by not later than 3:30 pm (Irish time) on the ‘business day’ following the date of the relevant transaction. This requirement will continue until the ‘offer period’ ends. If two or more persons cooperate on the basis of any agreement either express or tacit, either oral or written, to acquire an ‘interest’ in ‘relevant securities’ of MariaDB, they will be deemed to be a single person for the purpose of Rule 8.3 of the Irish Takeover Rules. A disclosure table, giving details of the companies in whose ‘relevant securities’ ‘dealings’ should be disclosed can be found on the Irish Takeover Panel’s website at www.irishtakeoverpanel.ie.

If two or more persons co-operate on the basis of an agreement or understanding, whether express or tacit, either oral or written, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3 of the Irish Takeover Rules.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1 and 8.2 of the Irish Takeover Rules).

In general, interests in securities arise when a person has long economic exposure, whether conditional or absolute, to changes in the price of the securities. In particular, a person will be treated as having an ‘interest’ by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Irish Takeover Rules, which can be found on the Irish Takeover Panel’s website.

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel’s website at www.irishtakeoverpanel.ie, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether or not you are required to disclose a ’dealing’ under Rule 8, please consult the Irish Takeover Panel’s website at www.irishtakeoverpanel.ie or contact the Irish Takeover Panel at telephone number +353 1 678 9020.

Publication on Website

In accordance with Rule 26.1 of the Irish Takeover Rules, a copy of this announcement will be available on K1’s website: https://k1.com/meridian promptly and in any event by no later than 12 noon on the business day following this announcement. The content of this website is not incorporated into and does not form part of this announcement.

GlobeNewswire Distribution ID 9038911

Tealium named a Leader in the first-ever Gartner® Magic Quadrant™ for Customer Data Platforms

As the CDP category reaches a maturity milestone, Tealium is recognized for its ability to execute and completeness of vision

San Diego, Feb. 16, 2024 (GLOBE NEWSWIRE) — Tealium, the largest independent and most trusted customer data platform (CDP), today announced that it was named a Leader in the first-ever Gartner® Customer Data Platforms Magic Quadrant™. This industry recognition marks a major milestone for CDPs and the maturity of the space on a global scale.

According to Gartner, Leaders execute well against their current vision and are well-positioned for tomorrow. The Gartner Magic Quadrant recognized Tealium as a Leader for its Ability to Execute and Completeness of Vision.

“We believe that this is a historic moment for the data sector, as Gartner acknowledges the maturity of the CDP space and its pivotal role in overall business success,” said Bob Page, Chief Product Officer at Tealium. “Customer success is our North Star, and to be positioned as a Leader on the industry’s very first CDP Magic Quadrant is a true testament to Tealium’s commitment to product innovation and customer-first excellence since we first pioneered the space in 2013.”

Tealium recently launched new solutions to help companies drive in-the-moment personalization for their customers, including Tealium for AITealium Moments, and Tealium’s Cloud Data Warehouse (CDW) Partner Ecosystem. The new releases fuel AI models with consented, filtered, and enriched data in real-time, allowing businesses to activate the most trusted experiences for their customers.

Additionally, Tealium differentiates against its competitors for its dynamic partner ecosystem, which includes over 1,300 turnkey connectors with the world’s most prominent media and technology experts, including Credera, a leading strategy, transformation, data, and technology consulting firm, and Ogilvy, one of the world’s largest advertising and communications firms.

“We believe that Tealium’s recognition as a Leader in the first-ever Gartner Magic Quadrant for Customer Data Platforms is a testament to their commitment to innovation and excellence in data management. As Chief Digital Officer at Credera, I have witnessed firsthand the transformative impact of Tealium’s solutions with a focus on benefits realization. We value our partnership with Tealium and its vendor-neutral capabilities,” said Phil Lockhart, Chief Digital Officer at Credera. “Tealium’s cutting-edge approach to data collection, enrichment, and real-time activation empowers businesses to unlock the full potential of their data and drive rapid growth. This accolade is well-deserved and reflects Tealium’s position as a proven leader of data technology.”

Ab Gaur, Global Chief Technology and Data Officer at Ogilvy, continues, “Tealium has been a pioneer in the CDP space since 2013, and their inclusion in the leadership quadrant of the first Gartner Magic Quadrant for Customer Data Platforms is a testament to this innovation and focus. Together, Ogilvy and Tealium are paving the way for transformative customer experiences and shared commitment, to delivering significant value for our mutual customers.”

Tealium was the first CDP to start with data collection and manages customer data throughout the entire journey. Serving more than 850 global enterprises with real-time-driven solutions, Tealium helps address industry-specific challenges and was one of the first companies to release a pharma and healthcare CDP solution that supports HIPAA-compliant initiatives.

A total of 18 CDP vendors were analyzed for the report. Gartner undergoes rigorous analysis for its Magic Quadrant findings, including expert-led, practitioner-sourced, and data-driven research. Access the report here.

To keep up with the latest company news, visit Tealium’s Newsroom.

Disclaimer *

Gartner, Magic Quadrant for Customer Data Platforms, Lizzy Foo Kune, Rachel Smith, Ben Bloom,

Suzanne White, Adriel Tel, David Walters, 2.14.2024

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, and MAGIC QUADRANT is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Tealium

As the most trusted CDP, Tealium connects customer data across web, mobile, offline, and IoT so businesses can better connect with their customers. Tealium’s turnkey integration ecosystem supports more than 1,300 built-in connections, empowering brands to create a complete, real-time customer data infrastructure. Tealium’s solutions include a customer data platform with machine learning, tag management, an API hub and data management solutions that make customer data more valuable, actionable, privacy-compliant and secure. More than 850 leading businesses throughout the world trust Tealium to power their customer data strategies. For more information, visit www.tealium.com

Natalie Passarelli
Tealium Inc. 
3129650210
[email protected]

GlobeNewswire Distribution ID 9038864

Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024

Nyxoah to Release Fourth Quarter and Financial Year 2023 Financial Results on March 5, 2024

Mont-Saint-Guibert, Belgium – February 15, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the fourth quarter and financial year 2023 on Tuesday, March 5, 2024, after market close. Company management will host a conference call to discuss financial results that day beginning at 10:30pm CET / 4:30pm ET.

A webcast of the call will be accessible via the Investor Relations page of the Nyxoah website or through this link: Nyxoah’s Q4 2023 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Nyxoah’s Q4 2023 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.

The archived webcast will be available for replay shortly after the close of the call.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
[email protected]
+1 310 310 1313

Attachment

GlobeNewswire Distribution ID 1000914070

Meltwater joins forces with Microsoft to bring to market the next-generation, AI-powered communication insights solution built on Microsoft Azure

SAN FRANCISCO, Feb. 15, 2024 (GLOBE NEWSWIRE) — Meltwater, a leading global provider of media, social, and consumer intelligence, today announced the launch of a market-making collaboration with Microsoft. Microsoft has signed with Meltwater as a provider of media, social, and consumer intelligence on a global scale. In turn, Microsoft will work with Meltwater to deliver an integrated communications insights solution, harnessing the capabilities of Meltwater’s leading listening tools alongside Microsoft’s technology stack, including Microsoft Azure, Microsoft 365, and Microsoft Teams. This solution will combine Microsoft’s advanced AI services with user-centric design to redefine the customer experience by turning data into dialogue, enabling better collaboration and quick action on business-critical news, market shifts, trends, and competitive intelligence. Meltwater also agreed to a multi-year commitment to make Microsoft Azure its preferred cloud platform for future Microsoft customer deployments.

In the era of AI, organizations need easy-to-use solutions that enable them to be more productive, more efficient, and more creative. Meltwater is taking its world-class data set and building on Microsoft’s industry-leading AI technologies to unlock data-driven insights and power better decision making. Together, they will develop a new generative AI-powered offering, with customer value at the center to solve critical customer challenges—faster.

The new solution will allow enterprise users of Copilot for Microsoft 365 and Microsoft Teams who are Meltwater customers to engage conversationally with Meltwater’s global data set, providing easy access to real-time insights such as brand mentions, sentiment analysis, key issues, and competitive benchmarking. This means that the right insight is not just a simple request away, but also presented in an easy-to-action, accessible way that drives strategic decisions, integrated directly inside of Teams. This builds on Meltwater’s existing integration with Teams, which is already bringing value to more than 1500 Meltwater customers with seamless delivery of AI-powered alerts right into Teams.

“By harnessing the power of Microsoft’s technology stack and AI capabilities, we’re pushing the boundaries of our existing integration further, allowing users to interact with Meltwater’s analytics tools through intuitive dialogue, asking questions and receiving insights as if they were conversing with a data-savvy colleague. Our aim is to transform the way insights are accessed and actioned, embedding Meltwater’s deep listening capabilities into the daily rhythm of business communications,” added John Box, CEO of Meltwater.

With this collaboration, Meltwater becomes a global provider of Microsoft’s media, social and consumer intelligence needs, enabling the Microsoft Communications organization and its internal stakeholders to access real-time insights across teams and geographies. “Our goal is to reinvent Communications using AI. We wanted to work with a partner that could help us deliver deeper insights using Microsoft’s AI technology in the place where our teams get their work done with Copilot for Microsoft 365 and Microsoft Teams. Meltwater’s leading technology and intuitive platform made them the best partner to help us build a solution that goes beyond hindsight reporting, delivering real time and AI-powered predictive insights.” said Steve Clayton, Vice President of Communications Strategy at Microsoft.

Meltwater will also be featured in the Azure Marketplace for all Microsoft customers to easily deploy Meltwater solutions, unlocking the power of the company’s deep data insights and coupled with the trusted Azure cloud platform. Meltwater will also participate in the Microsoft ISV Co-Sell Partner Program. “Meltwater is extremely excited to begin this powerful partnership with Microsoft, where the real winners will be our joint customers, who have access to market leading solutions run on the leading cloud platform,” said Doug Balut, SVP of Global Alliances and Partnerships at Meltwater.

For more info, please contact:
Kelly Costello
Corporate Communications Director
[email protected]

About Meltwater
Meltwater empowers companies with a suite of solutions that spans media, social, consumer and sales intelligence. By analyzing ~1 billion pieces of content each day and transforming them into vital insights, Meltwater unlocks the competitive edge to drive results. With 27,000 global customers, 50 offices across six continents and 2,300 employees, Meltwater is the industry partner of choice for global brands making an impact.
Learn more at meltwater.com.

GlobeNewswire Distribution ID 9037793

Anaqua Launches AnaquaGov Providing Enhanced Security and Controls for Managing Highly Sensitive IP Data

New, secure U.S. environment launches with NIST SP 800-171 assessment in anticipation of future CMMC certification

BOSTON, Feb. 15, 2024 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property (IP) management technology, today announced the launch of AnaquaGov™, providing U.S. defense contractors and all other clients handling U.S. CUI (Controlled Unclassified Information) with a specialized environment to manage their highly sensitive IP data.

In making the announcement, Anaqua confirmed that the AnaquaGov enclave fully meets NIST SP 800-171 compliance requirements—the strict standards set by the U.S. National Institute of Standards and Technology for safeguarding sensitive information on federal contractors’ IT systems and networks. This follows a review and validation of AnaquaGov by Schellman & Company, LLC, a leading CMMC third-party assessment organization (C3PAO). For this offering, Anaqua operates the AQX® IP Management System in the AnaquaGov enclave.

The development marks a significant step forward in Anaqua’s objective for AnaquaGov to obtain Cybersecurity Maturity Model Certification (CMMC)—the new standard designed to improve the cybersecurity readiness of businesses that work with the U.S. Department of Defense (DoD)—once the standard is finalized, and certifications are generally available.

Anaqua CEO Bob Romeo said: “At Anaqua, we pride ourselves on the security of our IP platform and the integrity of our data management, and we are delighted to have that further validated by Schellman. AnaquaGov represents another layer of security for our clients managing the most sensitive U.S. data and complements our ISO 27001, ISO 9001 and SOC 2 Type 2 certifications and global security programs. Through AnaquaGov, we now support client entities in managing their IP portfolios to the levels of security required by DoD. We are looking forward to CMMC certifications being available in the near future and we are ready.”

Anaqua CIO Erik Bailey further explained: “Many companies today that manage Controlled Unclassified Information—frequently under export control regulations—simply do not have access to a secure platform to perform their duties in a compliant manner. Through AQX hosted within the AnaquaGov enclave, we provide a comprehensive solution to entities that have, or suspect they have, CUI. These clients can carry out their responsibilities, securely, in an environment that has been independently assessed against stringent NIST controls and that is aligned with upcoming CMMC requirements.”

About Anaqua
Anaqua, Inc. is a premier provider of integrated intellectual property (IP) management technology solutions and services for corporations and law firms. Its IP management software solutions, AQX® and PATTSY WAVE®, both offer best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations, tailored to each segment’s need. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, Asia, and Australia. For additional information, please visit anaqua.com, or on Anaqua’s LinkedIn.

Company Contact:
Amanda Glagolev
Director, Communications
Anaqua
617-375-5808
[email protected]

GlobeNewswire Distribution ID 9037623

King Faisal Specialist Hospital & Research Centre Holds Firm as Global and Regional Healthcare Leader

King Faisal Specialist Hospital and Research Centre – Riyadh

King Faisal Specialist Hospital and Research Centre – Riyadh

RIYADH, Saudi Arabia, Feb. 15, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSH&RC) has once again secured its position for the second consecutive year as a global leader in healthcare and number one in the Middle East and Africa, ranking 20th globally among the leading healthcare institutions in the Brand Finance Global Top 250 Hospitals 2024 report. KFSH&RC continues to stand at the forefront both locally and regionally, underlining its commitment to delivering world-class patient-centric healthcare and medical innovation.

Leading the way, KFSH&RC is joined by King Saud Medical City, King Khalid University Hospital, National Guard Health Affairs, and King Fahd Medical City, all ranked among the top 100 globally. While King Fahd University Hospital and King Abdullah Medical City rank between 101 and 250. This assessment is based on insights from thousands of healthcare practitioners across over 30 countries.

The remarkable performance of KFSH&RC in this global ranking is a testament to the Kingdom’s healthcare transformation goals and the transformative impact of Vision 2030, reflected through the continuous improvement of healthcare services and the pursuit of technological advancements across the Kingdom for a healthier and thriving nation.

Brand Finance, founded in 1996, annually evaluates over 500 hospitals worldwide, utilizing more than 30 performance indicators encompassing healthcare, research centres, and education to support science-based strategic decision making.

King Faisal Specialist Hospital & Research Centre stands among the global leaders in providing specialized healthcare, driving innovation, and serving as an advanced hub for medical research and education. Through strategic partnerships with prominent local, regional, and international institutions, the hospital is dedicated to advancing medical technologies and elevating the standards of healthcare worldwide.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2024, “Brand Finance” ranked King Faisal Specialist Hospital & Research Centre as the top academic medical centre in the Middle East and Africa, and among the top 20 globally. Additionally, in 2022, it was recognized as one of the leading global healthcare providers by Newsweek magazine.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non-profit, government-owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1cab7add-5d3e-482c-bd5b-cc8856cf7875

CONTACT INFORMATION 

For more information please contact:

Mr. Essam Al-Zahrani, Acting Head of Media Affairs, 0555254429

Mr. Abdullah Al-Awn, Media Coordination Officer, 0556294232

GlobeNewswire Distribution ID 9038044